Black Rock Inc. Greenwich Life Sciences, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 308,909 shares of GLSI stock, worth $4.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,909

Previous 56,459 447.14%

Holding current value

$4.15 Million

Previous $1.13 Million 373.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$12.07 - $19.04 $3.05 Million - $4.81 Million	252,450 Added 447.14%	308,909 $5.33 Million
Q1 2024 May 10, 2024	SELL	$8.31 - $20.32 $5,725 - $14,000	-689 Reduced 1.21%	56,459 $1.13 Million
Q4 2023 Feb 13, 2024	BUY	$7.77 - $12.3 $8,997 - $14,243	1,158 Added 2.07%	57,148 $601,000
Q3 2023 Nov 13, 2023	SELL	$8.41 - $10.66 $13,329 - $16,896	-1,585 Reduced 2.75%	55,990 $494,000
Q2 2023 Aug 11, 2023	BUY	$9.58 - $13.2 $7,884 - $10,863	823 Added 1.45%	57,575 $555,000
Q1 2023 May 12, 2023	BUY	$12.12 - $20.8 $70,659 - $121,264	5,830 Added 11.45%	56,752 $782,000
Q4 2022 Feb 13, 2023	BUY	$9.04 - $16.88 $1,003 - $1,873	111 Added 0.22%	50,922 $774,000
Q3 2022 Nov 14, 2022	SELL	$7.81 - $12.02 $1,874 - $2,884	-240 Reduced 0.47%	50,811 $462,000
Q2 2022 Aug 12, 2022	SELL	$7.14 - $20.36 $1.32 Million - $3.77 Million	-185,204 Reduced 78.39%	51,051 $433,000
Q1 2022 May 12, 2022	SELL	$16.3 - $24.65 $27,775 - $42,003	-1,704 Reduced 0.72%	236,255 $4.64 Million
Q4 2021 Feb 10, 2022	BUY	$21.76 - $39.43 $437,484 - $792,740	20,105 Added 9.23%	237,959 $5.79 Million
Q3 2021 Nov 09, 2021	BUY	$38.65 - $46.11 $4,096 - $4,887	106 Added 0.05%	217,854 $8.51 Million
Q2 2021 Aug 11, 2021	BUY	$31.24 - $53.6 $6.8 Million - $11.7 Million	217,748 New	217,748 $9.79 Million

Others Institutions Holding GLSI

# of Institutions

Shares Held

1.01M

Call Options Held

Put Options Held

View Full List

About Greenwich LifeSciences, Inc.

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $173M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

More about GLSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account